COVID-19 Funding Opportunities
COVID-19 Federal Funding
Department of Commerce (DOC)
Department of Energy (DOE)
Department of Health and Human Services (HHS)
Department of State (DOS)
National Aeronautics and Space Administration (NASA)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Office of Science and Technology Policy (OSTP)
COVID-19 Non-Federal Funding
American Lung Association
Andrew W. Mellon Foundation
California Breast Cancer Research Program (CBCRP)
Coalition for Epidemic Preparedness Innovations (CEPI)
Stop the Spread
The Trinity Challenge
W.K. Kellogg Foundation
GrantForward has provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Grant COVID.
3/30 – National Institute of Standards and Technology (NIST) invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic. Learn more at NIST Manufacturing USA National emergency Assistance Program. Deadline: Rolling.
3/17 – The U.S. Department of Energy (DOE) encourages you to consider scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. Learn more at DOE Seeking Input and Collaboration on Science and Technology Response to COVID-19. Deadline: Rolling.
12/30 – The Centers for Disease Control is issuing a Broad Agency Announcement (BAA) Number 75D301-21-R-71738. THIS IS AN IMMEDIATE CALL FOR WHITE PAPERS.
- Genomic sequencing of SARS-CoV-2 to investigate viral evolution, and emergence and spread of infections in communities and populations.
- COVID-19 and Evaluating Effectiveness of Respiratory Virus Vaccines
- COVID-19 and Acute otitis media (AOM)
- COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C)
Learn more at 75D301-21-R-71738. Deadline: 3:00PM *Eastern Standard Time* on January 13, 2021
8/05 – The U.S. Department of State, Office of Global Partnerships (E/GP) is pleased to announce the COVID-19 Private Sector Engagement & Partnership Fund (Fund) Annual Program Statement (APS) that will be used make assistance awards. Learn more at COVID-19 Private Sector Engagement & Partnership Fund. Deadline: May 28, 2021.
7/09 – Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 pandemic. Learn more at Rapid Response and Novel Research in Earth Science. Deadline: Mar 29, 2021.
01/13 – The Agency for Healthcare Research and Quality (AHRQ) seeks applications to disseminate and implement in primary care practices the latest patient-centered outcomes research (PCOR) evidence regarding nonsurgical treatments for urinary incontinence in women. In addition, the COVID-19 epidemic has affected the availability of primary care visits. This funding announcement provides a unique opportunity to support primary care’s ability to deliver evidence-based interventions for UI in women, and to learn from implementation efforts. Learn more at RFA-HS-21-001. Deadline: February 24, 2021
01/11 – The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for a Data Coordinating Center for the HEALthy Brain and Child Development Study. Learn more at RFA-DA-21-023. Deadline: March 1, 2021.
01/11 – The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for a Consortium Administrative Core for the HEALthy Brain and Child Development (HBCD) Study. Learn more at RFA-DA-21-022. Deadline: March 1, 2021.
01/11 – The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for unlinked Research Project Sites for the HEALthy Brain and Child Development (HBCD) Study using the cooperative agreement award mechanism. Learn more at RFA-DA-21-021. Deadline: March 1, 2021.
01/11 – The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for linked Research Project Sites for the HEALthy Brain and Child Development (HBCD) Study using the cooperative agreement award mechanism. Learn more at RFA-DA-21-020. Deadline: March 1, 2021.
01/05 – The purpose of this Notice is to announce to potential applicants to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) an interest in research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission. Learn more at NOT-AR-21-012. Deadline: November 19, 2021.
12/23 – The purpose of this Notice is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that have been significantly impacted by the COVID-19 pandemic. Learn more at NOT-MH-21-120. Deadline: June 02, 2023
12/18 – The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. Learn more at NOT-TR-21-011. Deadline: June 02, 2021.
12/18 – This Notice of Special Interest (NOSI) highlights the need for research strategies and interventions to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities in the US.* Research is needed to understand and address misinformation, distrust, and hesitancy regarding vaccines (e.g., SARS-CoV-2, pneumococcal, influenza, hepatitis B, human papilloma virus (HPV), and herpes zoster) among adults in the United States and territories, especially in populations at increased risk for morbidity and mortality due to long-standing systemic health and social inequities and chronic medical conditions. The purpose of this NOSI is to solicit community-engaged research to: 1) evaluate intervention strategies (e.g., expand reach, access) to facilitate vaccination uptake in clinical and community contexts; and 2) address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. Learn more at NOT-MD-21-008. Deadline: January 08, 2022.
12/10 – This purpose of this Notice of Special Interest (NOSI) is to inform the extramural community about NHGRI’s interest in supporting research on pressing public health questions that can uniquely be addressed by collaborative efforts of large international cohort studies. Specifically, this call is limited to coordinated efforts focused on the collection and analysis of data or samples from ancestrally diverse cohorts of individuals participating in the International Hundred Thousand+ Cohort Consortium. Learn more at NOT-HG-21-020. Deadline: January 16, 2021.
11/17 – The purpose of this supplement is to provide support for successful applicants to develop partnerships with local worker centers and community organizations specifically targeting under served and disadvantaged communities with higher than average COVID-19 transmission rates. Learn more at NOT-ES-21-002. Deadline: December 30, 2020.
11/17 – The NIH Office of Science Policy (OSP) announces the availability of administrative supplements to support 1) research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity. Learn more at NOT-OD-21-020. Deadline: March 06, 2021.
11/13 – The purpose of this Notice of Special Interest (NOSI) is to alert the community about this opportunity and disseminate knowledge and information on a program designed to foster the expansion of U.S.-Finland biomedical and behavioral research collaboration. Finnish Center for Artificial Intelligence (FCAI) Flagship and Digital Precision Cancer Medicine Platform (iCAN) Flagship: Utilizing lessons learned from cancer research for treatments to COVID-19. Learn more at NOT-OD-21-021. Deadline: February 5, 2021.
11/13 – NIAID is issuing this Notice of Special Interest (NOSI) to highlight the critical need to develop prophylactic vaccines able to provide broad and durable protection against coronaviruses (CoVs), especially SARS-CoV-2 and others with pandemic potential. Learn more at NOT-AI-21-002. Deadline: June 12, 2021.
10/27 – The purpose of this notice is to communicate NIDA’s (National Institute on Drug Abuse) interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection. Learn more at NOT-DA-20-084. Deadline: September 08, 2024.
9/29 – The purpose of this NOSI is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation. Research applications addressing these topics are considered responsive; not all topics are expected within the same application. Applications will be directed to the National Center for Medical Rehabilitation Research (NCMRR) at NICHD. Learn more at NOT-HD-20-031. Deadline: May 08, 2023.
8/17 – The purpose of this funding opportunity announcement (FOA) is to support research on interventions to improve health in Native American (NA) populations. Existing data suggest that significant acute and chronic disease inequities exist for NA populations. Learn more at PAR-20-238. Deadline: May 17, 2021, May 17, 2022, May 17, 2023.
8/13 – The purpose of this Notice of Special Interest is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities. Learn more at NOT-MD-20-025. Deadline: May 08, 2023.
8/13 – This Notice of Special Interest encourages cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials, as defined by NIAID in PAR-18-633 and NOT-AI-16-084, that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate: SARS-CoV-2 candidate vaccines non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19 therapeutic approaches to treat COVID-19. Learn more at NOT-AI-20-065. Deadline: September 01, 2021.
8/05 – The purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The therapeutic agent must have already completed at least a Phase I clinical trial for a different indication, and not require additional regulatory studies for the new indication prior to starting a clinical trial. Learn more at RFA-TR-20-003. Deadline: Applications will be accepted on a rolling basis, beginning on August 6, 2020. All applications are due by 5:00 PM local time of applicant organization.
7/17 – The purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Learn more at PAR-20-256. Deadline: Rolling basis, until July 08, 2021.
7/06 – NIAID is issuing a notice to highlight very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support SARS-CoV-2 and COVID-19 research response. This NOSI replaces NOT-AI-20-034 which was rescinded with this issuance of this Notice. Learn more at NOT-AI-20-059. Deadline: July 02, 2020 through July 02, 2021.
6/26 – NIH has issued a notice to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations. Learn more at PAR-20-243. Deadline: March 2, 2021.
6/25 – Leidos Biomedical Research, Inc. (Leidos Biomed) has issued an RFP for Capacity Building Centers to support the Serological Sciences Network (SeroNet), developed to mobilize collaborative efforts to develop serological assays of high specificity and high sensitivity for deployment to test for SARS-CoV-2 induced immune responses and to rapidly expand national serological testing capacity. Learn more at NOT-CA-20-077.
6/25 – NIH has issued a notice to highlight the urgent need for research on COVID-19 in individuals with Down syndrome in conjunction with the INCLUDE Project. The overarching goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population, which may be disproportionately affected by, have higher infection rates of, and/or be at elevated risk for adverse outcomes from contracting the virus. Learn more at NOT-OD-20-129.
6/15 – NIH has issued a notice inviting applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19). Learn more at PAR-20-234. Deadline: January 4, 2021; and February 1, 2021.
6/15 – The National Center for Advancing Translational Sciences (NCATS) has issued a notice for Administrative Supplements (through PA-18-591) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients. Learn more at NOT-TR-20-029.
5/07 – The purpose of this Notice is to add a “third due date” and additional “areas of focus especially of interest” for PAR-19-373 and PAR-19-384 “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed/Basic Experimental Studies with Humans Required). Learn more at NOT-OD-20-103. Deadline: March 17, 2021.
4/30 – NINDS has issued a notice to highlight the urgent need for research on COVID-19 and on biological effects on the nervous system of its causative agent, SARS-CoV-2. Research of interest must fall within NINDS’s scientific mission, which is to support basic, translational, and clinical neuroscience research to expand fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. Learn more at NOT-NS-20-051. Deadline: April 15, 2021.
4/30 – NIAID has issued a FOA to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly for COVID-19. R21 Clinical Trial Not Allowed. Learn more at PAR-20-177. Deadline: Rolling.
4/30 – NIAID has issued a FOA to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly for COVID-19. R01 Clinical Trial Not Allowed. Learn more at PAR-20-178. Deadline: Rolling.
4/29 – The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Learn more at Rapid Acceleration of Diagnostics (RADx). Deadline: Rolling.
4/16 -National Institute on Alcohol Abuse and Alcoholism (NIAAA) has issued a notice to understand the potentially complex relationships between alcohol consumption and COVID-19 related-outcomes to enhance the nation’s response to the current pandemic. Learn more at NOT-AA-20-011. Deadline: April 16, 2021.
4/13 – This Notice of Special Interest (NOSI) highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. Learn more at NOT-OD-20-097. Deadline: Rolling through March 31, 2021.
4/10 – The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). The NIBIB is seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years. Learn more at NOT-EB-20-006. Deadline: March 31, 2021.
4/10 – National Institute of Biomedical Imaging and Bioengineering (NIBIB) has posted NOT-EB-20-007 and NOT-EB-20-008 to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). Deadline: March 31, 2021.
4/09 – National Institute of Environmental Health Sciences (NIEHS) is issuing this Notice of Special Interest (NOSI) to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Learn more at NOT-ES-20-015. Deadline: May 4, 2021.
4/09 – National Institute on Minority Health and Health Disparities (NIMHD) has issued a notice to highlight the urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations. Learn more at NOT-MD-20-019. Deadline: May 1, 2021.
4/09 – National Institute of Mental Health (NIMH) has issued a notice to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. Learn more at NOT-MH-20-047. Deadline: April 16, 2021.
4/09 – National Center for Advancing Translational Sciences (NCATS) has posted NOT-TR-20-016 and NOT-TR-20-017 to highlight the urgent need for research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines. Deadline: January 26, 2022.
4/02 – In order to rapidly improve understanding and available control measures for 2019-nCoV, National Institute on Aging (NIA) is encouraging the submission of applications for either Administrative Supplements (PA-18-591) or Competitive Revisions (PA-18-935) to active grants to address research areas of interest. Learn more at NOT-AG-20-022. Deadline: May 1, 2021.
3/27 – National Institute of Allergy and Infectious Diseases (NIAID) is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. Learn more at NOT-AI-20-031. Deadline: April 5, 2021.
3/25 – National Institute of General Medical Sciences (NIGMS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19). Learn more at NOT-GM-20-025. Deadline: February 6, 2021.
3/25 – National Institute of Allergy and Infectious Diseases (NIAID) is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. Learn more at NOT-AI-20-034. Deadline: March 25, 2021.
3/24 – National Center for Advancing Translational Sciences (NCATS) has issued this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. Learn more at NOT-TR-20-011. Deadline: July 10, 2021.
3/19 – NIH has issued a notice to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). National Institute on Drug Abuse (NIDA) is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Learn more at NOT-DA-20-047. Deadline: March 31, 2021.
07/17 – NSF has issued a notice to highlight the interest of existing programs in the Directorate for Biological Sciences (BIO) and the Directorate for Engineering (ENG) in interdisciplinary research for the development of novel biological platforms that are capable of sensing and responding to emerging infectious agents. The mechanism of sensing should be adaptable and or evolvable such that the sentinel cells, or other appropriate biotechnology solutions, are robust to a range of emergent threats, and/or can easily be reprogrammed and deployed once a new threat is identified. Learn more at NSF 20-105.
04/17 – NSF has issued a letter to researchers inviting proposals for rapid response research grants related to the virus. The letter welcomes studies to help understand COVID-19, inform and educate the public about virus transmission and prevention, and develop effective strategies for addressing this challenge at the local, state and national levels. Learn more at NSF 20-052. Deadline: Rolling.
3/16 – In response to the COVID-19 pandemic, the Allen Institute for AI has partnered with leading research groups to prepare and distribute the COVID-19 Open Research Dataset (CORD-19), a free resource of over 29,000 scholarly articles, including over 13,000 with full text, about COVID-19 and the coronavirus family of viruses for use by the global research community. The White House has issued a call to action to the Nation’s artificial intelligence experts to develop new text and data mining techniques that can help the science community answer high-priority scientific questions related to COVID-19. Learn more at Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset. Deadline: Rolling.
3/23 – Researchers are invited to submit COVID-19 related research proposals to the COVID-19 High Performance Computing Consortium via the online portal which will then be reviewed and matched with computing resources from one of the partner institutions. An expert panel of top scientists and computing researchers will work with proposers to quickly assess the public health benefit of the work and coordinate the allocation of the group’s powerful computing assets. Learn more at White House Announces New Partnership to Unleash U.S. Supercomputing Resources to Fight COVID-19. Deadline: Rolling.
GrantForward has provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Grant COVID. Candid has also provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Funding Opportunities.
4/20 – The American Lung Association is launching a $25M initiative to end COVID-19 and defend against future respiratory virus pandemics. Learn more at COVID-19 Action Initiative. Deadline: Rolling.
09/17 – As part its emergency grantmaking in the face of the global COVID-19 crisis, The Andrew W. Mellon Foundation announced today the launch of a new Art Museum Futures Fund — an emergency grant program starting with nearly $24 million to be distributed to 12 midsized art museums across the nation. Learn more at Art Museum Futures Fund.
08/07 – Established Products: Evaluate potential clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects, or antithrombotic benefits. Learn more at Investigator Initiated Studies (IIS). Deadline: Rolling.
04/06 – In light of the emergence and spread of COVID-19 in California and beyond, the statewide funding programs of the University of California Office of the President (UCOP) Research Grants Program Office (California Breast Cancer Research Program (CBCRP), Tobacco-Related Disease Research Program (TRDRP), California HIV/AIDS Research Program (CHRP)) and the Type 1 Diabetes Research Fund are together making available up to $2M to immediately support urgent research to mitigate the pandemic. Learn more at emergency COVID-19 Research Seed Funding. Deadline: Rolling.
2/14 – CEPI issues calls for proposals and requests for information inviting applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates. Learn more at Call for Proposals. Deadline: Rolling.
10/12 – Google has partnered with the Harvard Global Health Institute to fund companies, government agencies, non-profit organizations and academic institutions working on COVID-19 research. Researchers in approved countries are eligible to apply for COVID-19 related research credits. Learn more at Research Grants. Deadline: Rolling.
12/02 – The $300,000 KidneyX COVID-19 Kidney Care Challenge seeks solutions that reduce the transmission of the coronavirus among people living with kidney disease and/or reduce the risk of kidney damage among people who contract the virus. Have you developed a solution that could benefit others? Learn more at COVID-19 Kidney Care Challenge. Deadline: January 20, 2021.
01/12 – We are keenly focused on working with companies and organizations —large and small—to spur development of PPE for both medical and non-medical use, novel testing solutions, widely-accessible therapeutics and digital health solutions to address the needs of underserved communities and vulnerable populations. As the crisis evolves, we will continue to be responsive by tackling other urgent priorities. We also seek to connect with community and faith based organizations, community leaders, healthcare providers and philanthropists who would be interesting in partnering with us to #StoptheSpread in the hardest hit communities. Learn more at Stop the Spread. Deadline: ongoing.
01/15 – The Trinity Challenge seeks insights, new approaches and novel tools across the categories of (1) Identification, (2) Response and (3) Recovery. Learn more at The Trinity Challenge. Deadline: April 15, 2021.
01/12 – Children are at the heart of everything at the Kellogg Foundation. Their goal is lasting, transformational change for children. As a grantmaker, they recognize that children live in families and families live in communities. Therefore, their three areas of focused work – Thriving Children, Working Families and Equitable Communities – are dynamic and always interconnected. Learn more at Grantseekers. Deadline: Ongoing except between Jan. 23 through Mar. 14.